Author Archives: Andreas Scherer

Andreas Scherer

About Andreas Scherer

Andreas Scherer, Ph.D has managed global software and services businesses working for publicly traded companies such as Netscape and AOL as well as privately held companies. As part of his academic work, he has developed algorithms to conduct DNA sequence analysis. In the last decade, he has focused on accelerating R&D processes of Fortune 500 pharmaceutical, biotech, and medical device companies. As a result of this work, he is intimately familiar with the domestic and international life sciences market. Dr. Scherer holds a PhD in Computer Science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co- author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone,” is a prizewinner in the 2012 Eric Hoffer Book Awards competition and has been named a finalist in the 2012 Next Generation Indie Book Awards. Follow Andreas on Twitter @andreasscherer or connect with him on LinkedIn.

  

Golden Helix announces Partnership with Sentieon

Partnership with Sentieon

Today, we are happy to announce a multi-year partnership with Sentieon, a company that develops bioinformatics secondary analysis tools to process genomic data. This partnership will integrate Sentieon’s secondary analysis tools with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. Sentieon’s suite of secondary analysis tools made the significant improvement in runtime over BWA-MEM, GATK,… Read more »

Final thoughts on ACMG 2017

      Andreas Scherer    March 28, 2017    No Comments on Final thoughts on ACMG 2017
ACMG 2017

Last week was fast and furious for those of us who made it to Phoenix attending ACMG 2017. The event was exceptionally well attended, with great talks and sessions. Here are some of the highlights that are worth mentioning from our perspective. Numerous talks referenced how important the updated Exac/gnomAD database is for clinical NGS analysis. The new dataset includes… Read more »

PreventionGenetics adopts Golden Helix CNV analysis

Partnership with Sentieon

Today, I am happy to announce the introduction of VS-CNV for Gene Panels and Exomes. We have developed this capability in partnership with PreventionGenetics. PreventionGenetics will use VarSeq CNV for analysis of gene panels, and in the future for exome sequencing. The software gives PreventionGenetics the opportunity to conduct a comprehensive CNV analysis on NGS data, in many cases eliminating the need… Read more »

Golden Helix Among Top Biotech Solutions

top biotech solutions

CIO Review recently published its annual Biotech Technology Special Edition announcing the 20 most promising biotech technology solution providers. It is a great honor that Golden Helix has been named among the top 20 for the second year in a row! Please find my interview with the editor here: Spearheading Innovation in the Biotech Industry  We are very thankful for the hundreds of organizations and… Read more »

4th Annual Abstract Challenge Winners

4th Annual Abstract Challenge

This year’s annual Abstract Challenge was once again a successful event. We want to thank all that participated. This year we had nearly 50 submissions and our decision was a difficult one. Here are the selected winners. This year, we had dual first place winners; Reza Sailani and Jingga Inlora of the Michael Snyder lab in the Department of Genetics at… Read more »

A Year of Achievements

      Andreas Scherer    February 21, 2017    No Comments on A Year of Achievements
published

In the last year, Golden Helix has received several honors. We attribute these great achievements to our customers and the community. As we strive to provide the best analytics software available for both researchers and clinicians, the continued support, praise and referrals are monumental in our success. Pharma Tech Outlook selected Golden Helix as one of the top 10 Pharma… Read more »

NGS-Based Clinical Testing eBook

This generation of scientists, clinicians and bioinformaticians have already elevated the standards for diagnosis, prediction and care, ultimately improving patient outcome for millions of people by leveraging genomic information. This trend is only going to continue. Next-gen sequencing has made its way into the clinic. Golden Helix supports the adoption of Precision Medicine by building products, such as our VarSeq… Read more »

GWAS 3.0

      Andreas Scherer    February 7, 2017    No Comments on GWAS 3.0
GWAS eBook

Genome-wide association study (GWAS) technology has been a primary method for identifying the genes responsible for diseases and other traits for the past ten years. GWAS continues to be highly relevant as a scientific method. Over 2000 human GWAS reports now appear in scientific journals. In fact, we see its adoption increasing beyond the human-centric research into the world of… Read more »

NGS-Based Clinical Testing: Part VI

reporting incidental genetic findings

With a properly defined wet-lab and bioinformatics process, we are able to zero in on clinically relevant variants. How does a lab report on the outcome of their analysis? We find that most laboratories conduct their variant classification based on the guidelines formulated by the American College of Medical Genetics (ACMG) for inherited diseases. The ACMG guidelines for variant classification… Read more »

What to expect from Golden Helix in 2017

The year 2017 is starting fast and furious for us here at Golden Helix. We just announced a new imputation capability for our SVS product. At the same time, members of our team are on the way to PAG in San Diego to network with our clients in the Plant and Animal community. We have a terrific plan in place… Read more »

Call for abstracts!

      Andreas Scherer    December 13, 2016    No Comments on Call for abstracts!
Call for Abstracts

It is time to kick off our fourth annual abstract challenge! Our mission at Golden Helix is to enable Precision Medicine. We accomplish this by creating powerful software that enables both researchers and clinicians to complete complex analysis. This competition allows us to enable discovery by awarding software to those making an impact in the field. The competition has been… Read more »

Final thoughts on ASHG 2016

      Andreas Scherer    October 25, 2016    No Comments on Final thoughts on ASHG 2016
Customer Success

ASHG 2016 is in our rear mirror. Again, it was bigger and better than the previous year. The conference hosted over 9,000 visitors from 66 countries. This gave the event a level of vibrancy that was evenly matched by the wonderful ambiance of the city of Vancouver. Nestled in between the two conference centers was a little pier offering spectacular… Read more »

Genomic eBooks Series reached 10k Downloads!

10 k Downloads

Today we reached an important milestone. We have registered over 10,000 confirmed eBook downloads. Of course we are thrilled! Over the years, we aimed to contribute relevant content to the community. For some time, we have blogged and conducted webinars on the latest technology, methods and best practices. Our eBooks were the latest addition to this mix. We received a… Read more »

NGS-Based Clinical Testing: Part V

Quality Managment

Any validated bioinformatics pipeline must be continuously monitored. Quality management in clinical testing labs ensures that any divergence from predefined quality metrics during the analysis of clinical samples is investigated. For example: There is an insufficient number of sequence reads that passed the predefined base quality score threshold The number of variants identified in a data set may deviate substantially… Read more »

NGS-Based Clinical Testing: Part IV

clinical testing

After the Wet Lab process has been completed, the bioinformatics analysis of the sequencing data work begins. The next three blogs will focus on three aspects of this process. The building blocks of a bioinformatics pipeline, documentation and validation (today’s topic) Quality Management Clinical Reporting The Building Blocks of an NGS PipelineThe bioinformatics process to analyze NGS data occurs in three… Read more »

NGS-Based Clinical Testing: Part III

DNA sequencing

Getting the NGS wet bench process right is not a small undertaking. Targeted NGS assays such as multigene panels or exome sequencing allow for the targeted analysis of genomic regions that are of particular interest. For every sample type, e.g. blood, formalin-fixed paraffin-embedded specimens, saliva etc, there must be a detailed protocol in place outlining how each sample type is going… Read more »

NGS-Based Clinical Testing: Part II

ngs-based clinical testing

We have come a long way since Next-Generation Sequencing (NGS) evolved as a set of technologies in the 1970s. The higher throughput and rapid reduction of costs associated with NGS have lead to the accelerated adoption of clinical testing that we are experiencing today. Currently, it is applied to analyze inherited diseases, tumors, hematologic malignancies and infectious diseases. It is… Read more »

NGS-Based Clinical Testing: Part I

NGS Testing

The adoption of genetic services is key to our ability to provide personalized medicine in the future. The goal is to better diagnose diseases, predict their outcome, and choose the best possible care option for a patient. We still have a long way to go to achieve this goal. While there is agreement about the ultimate goal, there is still… Read more »

Launch of our Golden Helix eCommerce Store

Golden Helix eCommerce

Today, we launched our Golden Helix eCommerce Store. With this capability we respond to our customers requesting a simplified way to conduct business with us. Here is the background on this latest development. As we continue to grow in the genomics space, the needs of our clients fall really into two categories. On one hand, there are clients who want convenient access… Read more »

Advances in Medical Genetics Seminar and Workshop

Advances in Medical Genetics Seminar and workshop

Last week, I attended the Advances in Medical Genetics conference in Riyadh, Saudi Arabia. I was asked to present on “Big Data in DNA Analytics”. The event was hosted by Prof. Dr. Majid Alfadhel of the King Saud Bin Abdulaziz University for Health Sciences in collaboration with the Postgraduate Training Center. The event was held to discuss the pros and cons surrounding the… Read more »